Literature DB >> 27789716

Parametric Net Influx Rate Images of 68Ga-DOTATOC and 68Ga-DOTATATE: Quantitative Accuracy and Improved Image Contrast.

Ezgi Ilan1,2, Mattias Sandström3,2, Irina Velikyan3,4, Anders Sundin3,4, Barbro Eriksson5, Mark Lubberink3,2.   

Abstract

68Ga-DOTATOC and 68Ga-DOTATATE are radiolabeled somatostatin analogs used for the diagnosis of somatostatin receptor-expressing neuroendocrine tumors (NETs), and SUV measurements are suggested for treatment monitoring. However, changes in net influx rate (Ki) may better reflect treatment effects than those of the SUV, and accordingly there is a need to compute parametric images showing Ki at the voxel level. The aim of this study was to evaluate parametric methods for computation of parametric Ki images by comparison to volume of interest (VOI)-based methods and to assess image contrast in terms of tumor-to-liver ratio.
Methods: Ten patients with metastatic NETs underwent a 45-min dynamic PET examination followed by whole-body PET/CT at 1 h after injection of 68Ga-DOTATOC and 68Ga-DOTATATE on consecutive days. Parametric Ki images were computed using a basis function method (BFM) implementation of the 2-tissue-irreversible-compartment model and the Patlak method using a descending aorta image-derived input function, and mean tumor Ki values were determined for 50% isocontour VOIs and compared with Ki values based on nonlinear regression (NLR) of the whole-VOI time-activity curve. A subsample of healthy liver was delineated in the whole-body and Ki images, and tumor-to-liver ratios were calculated to evaluate image contrast. Correlation (R2) and agreement between VOI-based and parametric Ki values were assessed using regression and Bland-Altman analysis.
Results: The R2 between NLR-based and parametric image-based (BFM) tumor Ki values was 0.98 (slope, 0.81) and 0.97 (slope, 0.88) for 68Ga-DOTATOC and 68Ga-DOTATATE, respectively. For Patlak analysis, the R2 between NLR-based and parametric-based (Patlak) tumor Ki was 0.95 (slope, 0.71) and 0.92 (slope, 0.74) for 68Ga-DOTATOC and 68Ga-DOTATATE, respectively. There was no bias between NLR and parametric-based Ki values. Tumor-to-liver contrast was 1.6 and 2.0 times higher in the parametric BFM Ki images and 2.3 and 3.0 times in the Patlak images than in the whole-body images for 68Ga-DOTATOC and 68Ga-DOTATATE, respectively.
Conclusion: A high R2 and agreement between NLR- and parametric-based Ki values was found, showing that Ki images are quantitatively accurate. In addition, tumor-to-liver contrast was superior in the parametric Ki images compared with whole-body images for both 68Ga-DOTATOC and 68Ga DOTATATE.
© 2017 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  68Ga-DOTATATE; 68Ga-DOTATOC; net influx rate; neuroendocrine tumors; parametric images

Mesh:

Substances:

Year:  2016        PMID: 27789716     DOI: 10.2967/jnumed.116.180380

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  9 in total

1.  Quantitative Analysis of Heterogeneous [18F]FDG Static (SUV) vs. Patlak (Ki) Whole-body PET Imaging Using Different Segmentation Methods: a Simulation Study.

Authors:  Mingzan Zhuang; Nicolas A Karakatsanis; Rudi A J O Dierckx; Habib Zaidi
Journal:  Mol Imaging Biol       Date:  2019-04       Impact factor: 3.488

2.  68Ga-PSMA-11 PET/CT in prostate cancer local recurrence: impact of early images and parametric analysis.

Authors:  Christos Sachpekidis; Leyun Pan; Boris A Hadaschik; Klaus Kopka; Uwe Haberkorn; Antonia Dimitrakopoulou-Strauss
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-10-20

3.  In Vivo Instability of 177Lu-DOTATATE During Peptide Receptor Radionuclide Therapy.

Authors:  Mark Lubberink; Helena Wilking; Amalia Öst; Ezgi Ilan; Mattias Sandström; Camilla Andersson; Katarzyna Fröss-Baron; Irina Velikyan; Anders Sundin
Journal:  J Nucl Med       Date:  2020-01-31       Impact factor: 10.057

Review 4.  Influences on PET Quantification and Interpretation.

Authors:  Julian M M Rogasch; Frank Hofheinz; Lutz van Heek; Conrad-Amadeus Voltin; Ronald Boellaard; Carsten Kobe
Journal:  Diagnostics (Basel)       Date:  2022-02-10

5.  Pharmacokinetic analysis of [68Ga]Ga-DOTA-TOC PET in meningiomas for assessment of in vivo somatostatin receptor subtype 2.

Authors:  Asma Bashir; Mark Bitsch Vestergaard; Tina Binderup; Helle Broholm; Lisbeth Marner; Morten Ziebell; Kåre Fugleholm; Tiit Mathiesen; Andreas Kjær; Ian Law
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-03-13       Impact factor: 9.236

6.  Prospective study of dynamic whole-body 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumors.

Authors:  Philippe Thuillier; David Bourhis; Jean Philippe Metges; Romain Le Pennec; Karim Amrane; Ulrike Schick; Frédérique Blanc-Beguin; Simon Hennebicq; Pierre-Yves Salaun; Véronique Kerlan; Nicolas Karakatsanis; Ronan Abgral
Journal:  Sci Rep       Date:  2021-03-01       Impact factor: 4.379

Review 7.  Kinetic modeling and parametric imaging with dynamic PET for oncological applications: general considerations, current clinical applications, and future perspectives.

Authors:  Antonia Dimitrakopoulou-Strauss; Leyun Pan; Christos Sachpekidis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-05-19       Impact factor: 9.236

8.  Phantom Validation of a Conservation of Activity-Based Partial Volume Correction Method for Arterial Input Function in Dynamic PET Imaging.

Authors:  Brandon Driscoll; Tina Shek; Douglass Vines; Alex Sun; David Jaffray; Ivan Yeung
Journal:  Tomography       Date:  2022-03-21

9.  Evaluation of block-sequential regularized expectation maximization reconstruction of 68Ga-DOTATOC, 18F-fluoride, and 11C-acetate whole-body examinations acquired on a digital time-of-flight PET/CT scanner.

Authors:  Elin Lindström; Lars Lindsjö; Anders Sundin; Jens Sörensen; Mark Lubberink
Journal:  EJNMMI Phys       Date:  2020-06-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.